← Tutti gli studi Ultraprocessati

Ultraprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Santé Prospective Cohort.

Srour B, et al. · 2020
PubMed 31841598 ↗DOI: 10.1001/jamainternmed.2019.5942JAMA internal medicine
🌱 La lettura di LEO
⚓ Conferma: Peso del cibo · nella formula Vitalità
tocca anche ⚖️ Peso & grasso viscerale
Coorte prospettica di popolazione (104.707 persone; associazione, non causa)
La domanda

Gli ultraprocessati alzano il rischio di diabete tipo 2, o solo quello di altre malattie?

Cosa hanno trovato

104.707 partecipanti della coorte francese NutriNet-Sante' seguiti in media 6 anni (582.252 anni-persona, 821 nuovi casi), con la dieta rilevata da diari alimentari ripetuti di 24 ore. I tassi assoluti di diabete tipo 2 sono stati 113 per 100.000 anni-persona fra chi consumava meno ultraprocessati e 166 fra chi ne consumava di piu'. Per ogni aumento assoluto di 10 punti percentuali di ultraprocessati nella dieta, il rischio saliva del 15% (HR 1,15; IC 95% 1,06-1,25).

Cosa significa per te

E' il dato specifico sul diabete che mancava. Dieci punti percentuali di ultraprocessati in meno nella tua giornata — spesso e' una merendina e una bibita — valgono circa il 15% di rischio in meno. Non serve la perfezione: serve spostare la proporzione.

Abstract (in lingua originale)

IMPORTANCE: Ultraprocessed foods (UPF) are widespread in Western diets. Their consumption has been associated in recent prospective studies with increased risks of all-cause mortality and chronic diseases such as cancer, cardiovascular diseases, hypertension, and dyslipidemia; however, data regarding diabetes are lacking. OBJECTIVE: To assess the associations between consumption of UPF and risk of type 2 diabetes (T2D). DESIGN, SETTING, AND PARTICIPANTS: In this population-based prospective cohort study, 104 707 participants aged 18 years or older from the French NutriNet-Santé cohort (2009-2019) were included. Dietary intake data were collected using repeated 24-hour dietary records (5.7 per participant on average), designed to register participants' usual consumption for more than 3500 different food items. These were categorized according to their degree of processing by the NOVA classification system. MAIN OUTCOMES AND MEASURES: Associations between UPF consumption and risk of T2D were assessed using cause-specific multivariable Cox proportional hazard models adjusted for known risk factors (sociodemographic, anthropometric, lifestyle, medical history, and nutritional factors). RESULTS: A total of 104 707 participants (21 800 [20.8%] men and 82 907 [79.2%] women) were included. Mean (SD) baseline age of participants was 42.7 (14.5) years. Absolute T2D rates in the lowest and highest UPF consumers were 113 and 166 per 100 000 person-years, respectively. Consumption of UPF was associated with a higher risk of T2D (multi-adjusted hazard ratio [HR] for an absolute increment of 10 in the percentage of UPF in the diet, 1.15; 95% CI, 1.06-1.25; median follow-up, 6.0 years; 582 252 person-years; 821 incident cases). These results remained statistically significant after adjustment for several markers of the nutritional quality of the diet, for other metabolic comorbidities (HR, 1.13; 95% CI, 1.03-1.23), and for weight change (HR, 1.13; 95% CI, 1.01-1.27). The absolute amount of UPF consumption (grams per day) was consistently associated with T2D risk, even when adjusting for unprocessed or minimally processed food intake (HR for a 100 g/d increase, 1.05; 95% CI, 1.02-1.08). CONCLUSIONS AND RELEVANCE: In this large observational prospective study, a higher proportion of UPF in the diet was associated with a higher risk of T2D. Even though these results need to be confirmed in other populations and settings, they provide evidence to support efforts by public health authorities to recommend limiting UPF consumption. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03335644.
💬 Chiedi a LEO di spiegartelo
Come leggerlo: è uno studio scientifico peer-reviewed. Le evidenze aiutano a capire i trend, ma un singolo studio non è una prescrizione: parlane col tuo diabetologo prima di cambiare dieta o terapia.